Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: A randomized, double-blinded, placebo-controlled trial

British Journal of Anaesthesia

Volumn 112, Issue 3, 2014, Pages 485-490

  Chun, H R ^a   Jeon, I S ^b   Park, S Y ^a   Lee, S J ^a   Kang, S H ^a   Kim, S I ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

anti emetics; palonosetron; postoperative nausea and vomiting

Indexed keywords

METOCLOPRAMIDE; PALONOSETRON; PLACEBO;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ANTI-EMETICS; PALONOSETRON; POSTOPERATIVE NAUSEA AND VOMITING;

ADULT; AGED; ANTIEMETICS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; QUINUCLIDINES; RISK ASSESSMENT; SAMPLE SIZE; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896891110     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet340     Document Type: Article

References (18)

1. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-84
2. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesi-ology 1999; 91: 693-700
3. Kim SI, Kim SC, Baek YH, Ok SY, Kim SH. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth 2009; 103: 549-53
4. Ho KY, Gan TJ. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 2006; 19: 606-11
5. Wong EH, Clark R, Leung E, et al. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 1995; 114: 851-9
6. Stoltz R, Cyong JC, Shah A, Parisi S. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U. S. and Japanese healthy subjects. J Clin Pharmacol 2004; 44: 520-31
7. 3receptor internalization and causes prolonged inhibition of receptor function. Eur J Pharmacol 2010; 626: 193-9
8. Aapro MS, Grunberg SM, Manikhas GM, et al. A phase III, double-blind, randomized trial of palonosetron compared with ondanse-tron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006; 17: 1441-9
9. Eisenberg P, Figueroa-Vadillo J, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 2003; 98: 2473-82
10. Saito M, Aogi K, Sekine I, et al. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol 2009; 10: 115-24
11. Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C, Group P-S. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 2008; 107: 439-44
12. Candiotti KA, Kovac AL, Melson TI, Clerici G, Gan TJ, Group P-S. Aran-domized, double-blind study to evaluate the efficacy and safety of three differentdosesofpalonosetron versus placebo forpreventing postoperative nausea and vomiting. Anesth Analg 2008; 107: 445-51
13. Wang JJ, Ho ST, Uen YH, et al. Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline. Anesth Analg 2002; 95: 229-32
14. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-18
15. Apfel CC, Philip BK, Cakmakkaya OS, et al. Who is at risk for post-discharge nausea and vomiting after ambulatory surgery? Anes-thesiology 2012; 117: 475-86
16. Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure AF. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 2005; 101: 1343-8
17. Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68
18. Kim WO, Koo BN, Kim YK, Kil HK. Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis. Korean J Anesthesiol 2011; 61: 405-12